A randomized trial evaluating 2 approaches for promoting pharmacy-based referrals to the tobacco quitline: methods and baseline findings.

Research in Social & Administrative Pharmacy : RSAP
Alan J ZillichKaren Suchanek Hudmon

Abstract

Despite the fact that individuals who smoke are at an increased risk for disease and therefore require frequent visits to pharmacies for medications, most community pharmacies do not integrate tobacco cessation activities into routine practice. The objective of this report is to describe the methods and baseline findings for a 2-state randomized trial evaluating 2 intervention approaches for increasing pharmacy-based referrals to their state's tobacco quitline. Participating community pharmacies in Connecticut (n=32) and Washington (n=32) were randomized to receive either (1) on-site education with an academic detailer, describing methods for implementing brief interventions with patients and providing referrals to the tobacco quitline or (2) quitline materials delivered by mail. Both interventions advocated for pharmacy personnel to ask about tobacco use, advise patients who smoke to quit, and refer patients to the tobacco quitline for additional assistance with quitting. Study outcome measures include the number of quitline registrants who are referred by pharmacies (before and during the intervention period), the number of quitline materials distributed to patients, and self-reported behavior of cessation counseling and quit...Continue Reading

References

Jan 26, 1990·JAMA : the Journal of the American Medical Association·S B Soumerai, J Avorn
Jan 1, 1993·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·M B DalyP F Engstrom
Apr 1, 1996·Archives of Family Medicine·T S CaudillW P McKinney
May 7, 1996·Health Education Research·E LichtensteinS M Boles
Apr 12, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Susan H SwartzMichael G Goldstein
May 28, 2002·Journal of the American Pharmaceutical Association : APhA·Jeremy A MargolisShaohua Hu
May 14, 2003·Pharmacotherapy·Mary L AquilinoJohn B Lowe
Oct 22, 2004·Journal of the American Pharmacists Association : JAPhA·Alan J ZillichKaren B Farris
Jan 11, 2005·Journal of the American Pharmacists Association : JAPhA·Larry A DentEvan Lewis
Jan 14, 2005·The Journal of the American Dental Association·David A AlbertDonald Sadowsky
Jul 28, 2005·JAMA : the Journal of the American Medical Association·Steven A Schroeder
Mar 15, 2006·Patient Education and Counseling·Karen Suchanek HudmonRobin L Corelli
Oct 14, 2006·Journal of the American Pharmacists Association : JAPhA·Jessica L PurcellMary L Aquilino
Jun 28, 2007·Pharmacotherapy·Larry A DentCurtis W Noonan
Jul 12, 2008·American Journal of Preventive Medicine·UNKNOWN Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff
Jan 10, 2009·Journal of Community Health·Angela MeshackAlfred L McAlister
May 9, 2009·Journal of General Internal Medicine·Melissa A FischerJerry H Gurwitz
Feb 18, 2010·The International Journal of Pharmacy Practice·Pallavi D Patwardhan, Betty A Chewning
Mar 5, 2010·American Journal of Preventive Medicine·Catherine Bonniot Saucedo, Steven A Schroeder
Jul 16, 2010·The Annals of Pharmacotherapy·Scott A BaggarlyBenny L Blaylock
Sep 14, 2010·Journal of the American Pharmacists Association : JAPhA·Pallavi D Patwardhan, Betty A Chewning
Sep 14, 2010·Journal of the American Pharmacists Association : JAPhA·Larry A DentCurtis W Noonan
Oct 13, 2010·Archives of Internal Medicine·Alexander V ProkhorovEllen R Gritz

❮ Previous
Next ❯

Citations

Jul 24, 2014·International Journal of Clinical Pharmacy·Lucas Miyake OkumuraCassyano Januário Correr
Jul 11, 2013·BMC Research Notes·Pallavi PatwardhanJonathan P Winickoff
Mar 13, 2014·Research in Social & Administrative Pharmacy : RSAP·Sharon E ConnorMary I Herbert
Aug 4, 2015·Journal of Substance Abuse Treatment·Lori J DucharmeAlex H S Harris
Jul 19, 2018·The International Journal of Pharmacy Practice·Shane P DesselleLemuel Zamora
Jul 31, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Dennis K Helling, Samuel G Johnson
Jan 9, 2020·Australian and New Zealand Journal of Public Health·Louise MarshFrederieke Sanne Petrović-van der Deen
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Kristin V Carson-ChahhoudChristine M Bond

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved